INTRODUCTION
============

Epilepsy, a chronic neurological disorder that is characterized by spontaneous recurrent seizures (SRS), is the fourth most common neurological disorder ([@b32-ZoolRes-38-4-171]). Epilepsy was first described over 2 500 years ago, yet there is still relatively little known about the underlying cause and currently no disease-modifying therapies exist. Current treatment options include antiepileptic drugs (AEDs), ketogenic diet, neurosurgical resection, and electrical stimulation of the central nervous system (CNS), which work for some but not all afflicted individuals ([@b49-ZoolRes-38-4-171]). Thus, there is an urgent unmet clinical need to discover treatments for the entire epileptic population. Most currently available AEDs were first identified using simple acute seizure models (i.e., pentylenetetrazol induced seizure and maximal electroshock seizure models) ([@b54-ZoolRes-38-4-171]). These acute models fail to mirror the spontaneous nature of seizures seen in epilepsy. This issue is hypothesized to contribute to the large percentage of epileptic patients (∼30%) for whom AEDs fail to prevent or control SRS. Therefore, studying epilepsy using laboratory animals exhibiting SRS will provide an important tool to explore the underlying mechanism of epilepsy and develop novel therapeutic approaches.

Epilepsy has been studied in a wide range of species of laboratory animals from simple organisms (e.g., *Drosophila melanogaster*, *Caenorhabditis* *elegans* and *Danio rerio*) to non-human primates. Along this spectrum, *Rattus norvegicus* (rat) and *Mus musculus* (mouse) are the two most commonly used laboratory animals given their small size, docility, rapid breeding, and availability of advanced genetic tools. Importantly, rat and mouse models provide good construct, face, and predictive validities of epilepsy and demand relatively low cost and maintenance for chronic study of SRS. In this review, we discuss the methodology of SRS recording, and summarize both genetic and acquired models of SRS in rat and mouse, with particular emphasis on modeling and detection of SRS. Mechanism and treatment of epileptogenesis are addressed in other reviews ([@b27-ZoolRes-38-4-171]; [@b55-ZoolRes-38-4-171]; [@b59-ZoolRes-38-4-171]; [@b70-ZoolRes-38-4-171]; [@b84-ZoolRes-38-4-171]).

MONITORING AND DETECTION OF SRS IN RODENTS
==========================================

Chronic recording and detection of SRS in rodents is fundamental for preclinical research of epilepsy. Rigorous monitoring of SRS requires continuous time-locked video-EEG 24/7 in freely moving rodents. To capture biopotentials of the brain, most studies utilize single or multiple unipolar or bipolar recording electrodes which are intracranially placed. Skull or intracerebral electrode arrays are also used to cover broader brain regions. EEGs are acquired via either tethered or telemetry (wireless) recording systems in free-roaming, conscious rodents ([Figure 1A](#F1-ZoolRes-38-4-171){ref-type="fig"}). If a telemeter is used, it is either directly mounted on the head or tunneled and secured subcutaneously on the back or abdomen of rodents, providing the advantage of eliminating a wired interface between the animal and instrumentation. This minimizes the electrical noise and movement artifacts inherent in a tethered system. An inductive charging technique enables the telemeter to work 24/7 without the interruption of recharging the batteries.

![Schematic of video-EEG recording and EEG analyses](ZoolRes-38-4-171-g1){#F1-ZoolRes-38-4-171}

Given the rare, unpredictable nature and extremely diverse morphologies of SRS, identification of SRS is a technically challenging task. In most basic research settings, off-line visual inspection of EEG is performed by investigators to identify possible discrete epileptiform episodes, which are further confirmed by reviewing the time-locked video for behavioral correlates. Typical electrographic SRS features rhythmic neuronal firing characterized by increase of frequency and amplitude (especially in the gamma band) with clear initiation, propagation and termination ([Figure 1B](#F1-ZoolRes-38-4-171){ref-type="fig"}, left panel). In rodents, discrete epileptic discharges typically last seconds and are frequently followed by postictal suppression, which lasts minutes until normal electrographic activities resume. Electrographic SRS coincide with behavior phenotypes including rigid posture, facial automatisms, myoclonus, jumping and wild running, loss of postural control, tonic hindlimb extension, and death, which can be further semi-quantified using modified Racine's scale ([@b2-ZoolRes-38-4-171]; [@b72-ZoolRes-38-4-171]). Spontaneous absence seizures characterized by spike-wave discharges (SWD) and behavioral arrest are also frequently observed in some models.

To achieve successful SRS monitoring and detection, the following factors also need to be considered: (1) depending on models, SRS are relatively rare and tend to cluster. The seizure-free latent or interictal period may last days or even weeks before first or subsequent SRS emerge. Therefore, long-term (weeks to months) recording is required to achieve meaningful interpretation; (2) in most studies, brain areas covered by electrodes are limited. Electrographic seizures may occur out of the recording site, and in the absence of overt behavior change; (3) rodents are commonly singly housed during monitoring to minimize damage of recording device and facilitate video analysis. How social isolation affects SRS needs to be evaluated; (4) to visualize animal behavior during dark cycles, in some studies, the recording area is illuminated, thereby disrupting the normal light/dark cycle of monitored animals. Infrared light and imaging devices are recommended for behavior monitoring during dark cycle if circadian rhythm is considered ([@b16-ZoolRes-38-4-171]; [@b34-ZoolRes-38-4-171]); (5) SRS automatic detection algorithm is available, but manual validation is strongly recommended.

SRS IN RODENT MODELS OF EPILEPSY
================================

SRS in genetic models of epilepsy
---------------------------------

Approximately 40% of epilepsies are idiopathic. Genetics play a significant role in the development, maintenance, and difficulty of treating epilepsy. A growing number of epilepsy-related single gene mutations have been identified. Animals possessing analogous genetic manipulations (engineered or spontaneous) have proven useful in the search for the possible treatment for idiopathic epilepsy ([Table 1](#T1-ZoolRes-38-4-171){ref-type="table"}).

###### 

SRS in transgenic models of epilepsy

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                                    Modification                                                    Latency                                                                                             Frequency and features of SRS                                                                   References
  --------------------------------------- --------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------
  *Scn1a*                                 *Scn1a*^-/-^                                                    P9                                                                                                  Generalized convulsive SRS. SUDEP at P15                                                        [@b89-ZoolRes-38-4-171]

  *Scn1a*^+/-^                            P21--P27                                                        EEG and/or behavioral SRS lasted 20 s. Sporadic SUDEP from P21^\*^                                                                                                                                  

  *Scn1a*^Flox/+^*::* *Zp3-Cre^+/-^*      N/A                                                             12 out of 23 mice exhibited behavioral SRS (3 times/day, lasted 35 s). Lifespan of P33              [@b23-ZoolRes-38-4-171]                                                                         

  *Scn1a*^Flox/+^*::* *Ppp1r2-Cre^+/-^*   N/A                                                             2 out of 6 mice exhibited behavioral and/or EEG SRS                                                                                                                                                 

  *Scn1a*^R1407X/R1407X^                  P12--P16                                                        Multiple tonic-clonic SRS/day confirmed by EEG (lasted 1--3 min, interval: 1--4 hr). SUDEP by P21   [@b66-ZoolRes-38-4-171]                                                                         

  *Scn1a*^R1407X/+^                       P18                                                             Sporadic SUDEP in 1--3 mo^\*^                                                                                                                                                                       

  *Scn1a*^R1648H/R1648H^                  P16                                                             Behavioral SRS lasted 30--90 s. SUDEP P16--P26                                                      [@b57-ZoolRes-38-4-171]                                                                         

  *Scn1a*^R1648H/+^                       N/A                                                             2 out of 14 mice exhibited 21 SRS in total during 96 h EEG recording                                                                                                                                

  *Scn2a*                                 *Scn2a*^Q54^                                                    2 mo^\*^                                                                                            EEG and behavioral SRS. Frequency and duration of SRS increased with age^\*^                    [@b43-ZoolRes-38-4-171]

  *Scn8a*                                 *Scn8a*^8J/+^*, Scn8a*^med/+^*or Scn8a*^med-jo/+^               N/A                                                                                                 SWD with behavioral arrest^\*^                                                                  [@b68-ZoolRes-38-4-171]

  *Scn8*^N1768D/N1768D^                   3 wk                                                            No SRS prior to day of SUDEP 3 wk. SRS lasted \<1 min                                               [@b85-ZoolRes-38-4-171]                                                                         

  *Scn8*^N1768D/+^                        8--16 wk                                                        0--3 SRS/day. SRS lasted \<1 min. SUDEP 14 wk                                                                                                                                                       

  *Scn8*^N1768D/-^                        8 wk                                                            As many as 25 SRS/day. SUDEP 9 wk                                                                                                                                                                   

  *Scn1b*                                 *Scn1b^-/-^* or *Scn1b^del/del^*                                P10                                                                                                 EEG and behavioral SRS at random intervals with duration from seconds to minutes. SUDEP 3 wk    [@b12-ZoolRes-38-4-171]; [@b13-ZoolRes-38-4-171]

  *Kcnq2*                                 *Kcnq2*^A306T/A306T^                                            P24                                                                                                 Generalized EEG and behavioral SRS. SUDEP P16--P32^\*^                                          [@b77-ZoolRes-38-4-171]

  *Kcnq3*                                 *Kcnq3*^G311V/G311V^                                            2 wk                                                                                                Generalized EEG and behavioral SRS. SUDEP P0--P73^\*^                                           [@b77-ZoolRes-38-4-171]

  *Kcna1*                                 *Kcna1*^-/-^                                                    3 wk                                                                                                Behavioral SRS lasted 20 s--2 min once or twice/hr throughout adult life. SUDEP 3--5 wk         [@b78-ZoolRes-38-4-171]

  *Kcna2*                                 *Kcna2*^-/-^                                                    N/A                                                                                                 Tonic-clonic SRS. SUDEP at P17                                                                  [@b7-ZoolRes-38-4-171]; [@b21-ZoolRes-38-4-171]

  *Kcnmb4*                                *Kcnmb4^-/-^*                                                   N/A                                                                                                 Generalized EEG seizures without overt behavioral manifestation                                 [@b6-ZoolRes-38-4-171]

  *Cacna1a*                               Deletion (α~1A~^−/−^)                                           N/A                                                                                                 Absence seizures. SUDEP 3--4 wk                                                                 [@b40-ZoolRes-38-4-171]

  *Gria2*                                 *Gria2*^+/ΔECS^                                                 P12                                                                                                 Behavioral SRS (once/4 hr). SUDEP by P20                                                        [@b8-ZoolRes-38-4-171]

  *Chrna4*                                *Chrna4*^S252F/S252F\ or\ +^ and *Chrna4*^+L264/+L264\ or\ +^   N/A                                                                                                 SRS with high-amplitude, low-frequency cortical EEG activity, prominent theta and delta waves   [@b47-ZoolRes-38-4-171]

  *Gabrg2*                                *Gabrg2*^+/-^ or *Gabrg2*^+/R43Q^                               P20                                                                                                 Behavioral arrest and associated SWD^\*^\                                                       [@b74-ZoolRes-38-4-171]; [@b80-ZoolRes-38-4-171]
                                                                                                                                                                                                              (up to 50 times/hr and variable)                                                                

  *Tsc1/2*                                *Tsc1/2^flox/flox^::GFAP-Cre*                                   2--3 wk                                                                                             Generalized tonic-clonic SRS. Few SRS at 3 wk, frequency increased over time. SUDEP 7--10 wk    [@b91-ZoolRes-38-4-171]

  *Fgf13*                                 *Fgf13*^+/-^                                                    P15                                                                                                 Behavioral and EEG SRS. Frequency and duration varied by animal                                 [@b71-ZoolRes-38-4-171]

  *Lgi1*                                  *Lgi1*^-/-^                                                     P10                                                                                                 Clonic SRS (1.6 seizures/hr at P14). SUDEP at P20                                               [@b10-ZoolRes-38-4-171]

  *BACE1*                                 *BACE1*^-/-^                                                    N/A                                                                                                 \<40% rats exhibited generalized SRS and/or absence seizures                                    [@b33-ZoolRes-38-4-171]

  *APP*                                   *APdE9*                                                         N/A                                                                                                 65% exhibited SRS, 10%--15% mortality at any age but peak around 3--4 mo                        [@b60-ZoolRes-38-4-171]

  *hAPP~FAD~*                             N/A                                                             Spontaneous nonconvulsive seizure activity. Occurrence of SUDEP                                     [@b67-ZoolRes-38-4-171]                                                                         

  *Ube3a*                                 *Ube3a*^m+/p-^                                                  P18                                                                                                 SWD accompanied by behavioral immobility or tonic-clonic SRS^\*^                                [@b61-ZoolRes-38-4-171], [@b36-ZoolRes-38-4-171]; [@b38-ZoolRes-38-4-171]

  *Mecp2*                                 *Viaat-Mecp2^−/y^* *Mecp2^308/y^*                               5 wk N/A                                                                                            Spontaneous rhythmic EEG activity including SWD^\*^ Spontaneous behavioral myoclonic jerks      [@b11-ZoolRes-38-4-171] [@b19-ZoolRes-38-4-171]

  *Shank3*                                *Shank3* *OE*                                                   N/A                                                                                                 Hyperexcitability discharges accompanied by EEG SRS                                             [@b29-ZoolRes-38-4-171]

  *CNTNAP2*                               *CNTNAP2^-/-^*                                                  6 mo                                                                                                SRS with generalized interictal spike discharges                                                [@b69-ZoolRes-38-4-171]

  *Epm2A*                                 *Epm2A^-/-^*                                                    \<9 mo                                                                                              80% exhibited myoclonic SRS, more frequent during dark cycle                                    [@b25-ZoolRes-38-4-171]

  *Celf4*                                 *Celf4^Ff/Ff^ or Celf4^Ff/+^*                                   3 mo                                                                                                Recurrent tonic-clonic seizures or absence seizures^\*^                                         [@b88-ZoolRes-38-4-171]

  *Map2k1*                                *caMEK1^flox/flox^::Nestin-Cre*                                 6--8 wk                                                                                             Lifetime behavioral arrest and forelimb myoclonus (6.2 SRS/7 hr)                                [@b62-ZoolRes-38-4-171]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ion channel genes
-----------------

Ion channels control the electrical transduction of cells, thereby playing a pivotal role in regulating neuronal excitability. Most epilepsy-related genes encode proteins composing voltage- or ligand-gated ion channels. Below we summarize genetic models of epilepsy that result from mutations in various types of ion channels.

Of the many ion channels, a number of disruptions in genes encoding voltage-gated sodium channels have been described in multiple human epilepsies, including genetic epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome. Disruptions of genes encoding either α (SCN1A, SCN2A and SCN8A) or β (SCN1B) subunits of voltage-gated sodium channels are sufficient to trigger SRS in rodents ([@b12-ZoolRes-38-4-171], [@b13-ZoolRes-38-4-171]; [@b23-ZoolRes-38-4-171]; [@b43-ZoolRes-38-4-171]; [@b57-ZoolRes-38-4-171]; [@b66-ZoolRes-38-4-171]; [@b68-ZoolRes-38-4-171]; [@b85-ZoolRes-38-4-171]; [@b89-ZoolRes-38-4-171]). In addition, two modifier loci (*Moe1* and *Moe2*) and multiple candidate modifier genes that influence the *Scn2a^Q54^* epilepsy phenotype have also been identified and refined ([@b31-ZoolRes-38-4-171]).

Potassium channels also play an important role in action potentials by helping to return the neuron back to its resting membrane potential. *Kcna1* and *Kcna2* encode a pair of proteins (Kv1.1 and 1.2) which are members of the voltage-dependent potassium channel subfamily A. *Kcna1*or *Kcna2* knockout mice display frequent, severe SRS throughout their lives. In addition, SRS caused death in 50% of *Kcna1* or *Kcna2* knockout mice beginning from three weeks of age ([@b7-ZoolRes-38-4-171]; [@b21-ZoolRes-38-4-171]; [@b78-ZoolRes-38-4-171]). Mutations of *Kcnq2* and *Kcnq3*, which encode subfamily Q of voltage-gated potassium channels have been found in patients with benign familial neonatal convulsions (BFNC). *Kcnq2* or *Kcnq3* mutant mice exhibit early onset generalized tonic-clonic SRS concurrent with M-current defects ([@b77-ZoolRes-38-4-171]). Mice carrying *Scn2a^Q54^* transgene together with *Kcnq2* mutations (*Szt1* or V182M) result in an exacerbated epileptic phenotype ([@b44-ZoolRes-38-4-171]). A gain-of-function mutation of gene *Kcnmb4,* which encodes calcium-activated potassium channel accessory β4 subunit also led to SRS ([@b6-ZoolRes-38-4-171]).

Calcium channels are important for neuronal excitability and intracellular signaling. Activation of T-type calcium channels evoke burst-firing in the thalamocortical circuitry that gives rise to SWD associated with absence epilepsy ([@b14-ZoolRes-38-4-171]; [@b15-ZoolRes-38-4-171]). α1G T-type calcium currents play a critical role in the genesis of spontaneous absence seizures resulting from hypofunctioning P/Q-type channels (*α1~A~^−/−^*) ([@b40-ZoolRes-38-4-171]; [@b79-ZoolRes-38-4-171]). These attacks have also been shown to reflect absence seizures in *tottering* (*tg*), *leaner* (*tg^la^*) and *rocker* (*rkr*) mice, which have spontaneously occurring mutant ([@b24-ZoolRes-38-4-171]; [@b40-ZoolRes-38-4-171]; [@b93-ZoolRes-38-4-171]). In addition to pore-forming α1 subunit, loss of function mutations in ancillary subunits of calcium channels, including naturally occurring mutations in the β subunit gene *Cchb4* in the lethargic (*lh*) mouse, loss of α2δ2 subunit protein in *ducky* mouse (*du* and *du^2j^*) and dysfunctional calcium channel γ2 subunits in *stargazer* (*stg*) and *waggler* (*wgl*) mice also result in SRS ([@b9-ZoolRes-38-4-171]; [@b90-ZoolRes-38-4-171]).

In addition to voltage-gated ion channels, mutations of ligand-gated ion channel genes also result in SRS in mice. Heterozygous mice carrying an editing-deficient GRIA2 subunit allele express AMPA receptors with increased calcium permeability and develop SRS ([@b8-ZoolRes-38-4-171]). Fast ionotropic nicotinic acetylcholine receptor (nAChR) subunit genes, α2 (*Chrna2*), α4 (*Chrna4*) and β2 (*Chrnb2*), have been affiliated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) when mutated. Mice with *Chrna4* mutations (*Chrna4*^S252F^ or *Chrna4*^+L264^) exhibited frequent SRS with diverse seizure semiology ranging from behavioral arrest to convulsive jerking ([@b47-ZoolRes-38-4-171]). GABA~A~ γ2-subunites have five known seizure associated mutations. Of these mutations, the R43Q mutation is of particular interest because it is related to childhood absence epilepsy and febrile seizures ([@b86-ZoolRes-38-4-171]). Both heterozygous *Gabrg2* knock-out and R43Q knock-in mice exhibited spontaneous absence seizures accompanied by SWD ([@b74-ZoolRes-38-4-171]; [@b80-ZoolRes-38-4-171]).

Non-ion channel genes
---------------------

SRS are also related to interruptions of non-ion channel genes that are involved in diverse neurological disorders including tuberous sclerosis complex (TSC), Alzheimer's disease (AD) and autism. Notably, SRS can arise as a comorbid phenotype and/ or secondary consequence of gene modification from germline.

Epilepsy is the most common presenting symptom in TSC. Up to 80%--90% of individuals with TSC will develop epilepsy during their lifetime. Two genes, *TSC1* and *TSC2*, encoding the proteins hamartin and tuberin, respectively, have been identified as causing TSC. Both genes, when conditionally inactivated in mice, have been shown to contribute to epileptic phenotype, among which *Tsc2* led to more severe and frequent seizures ([@b91-ZoolRes-38-4-171]).

Prevalence of epilepsy in Alzheimer's disease is significantly higher than in age-matched control populations. Manipulation of AD related genes (e.g., *BACE1* and *APP*) can also cause SRS in mice. One study showed that *BACE1* knockout mice were predisposed to both spontaneous and chemically induced seizures ([@b33-ZoolRes-38-4-171]). Autosomal-dominant mutations in amyloid precursor protein (APP) cause hereditary early-onset familial Alzheimer\'s disease (FAD). Transgenic mice overexpressing a mutant form of human APP (*hAPP~FAD~*) have spontaneous nonconvulsive seizure activity in cortical and hippocampal networks ([@b67-ZoolRes-38-4-171]). It was shown that 65% of mice carrying human APP with Swedish double mutation (*APPswe*) cointegrated with human preselinin-1 with exon 9 deletion (*PS1dE9*) exhibited unprovoked seizures ([@b60-ZoolRes-38-4-171]; [@b83-ZoolRes-38-4-171]).

Autism spectrum disorder (ASD) related genes are also extensively studied given the fact that epilepsy is common in individuals with autistic-like behavior resulting from particular genetic predisposition. A null mutation of maternal *Ube3a* gene (exon 1--2 or exon 15 and 16) results in core pathologies of Angelman syndrome including spontaneous EEG abnormality in mice ([@b37-ZoolRes-38-4-171]; [@b61-ZoolRes-38-4-171]). Spontaneous behavioral seizures were witnessed in mice with 1.6Mb large deletion (*Ube3a* to *Babrb3*) and loss of *Ube3a* selectively from the GABAergic neurons ([@b38-ZoolRes-38-4-171]; [@b39-ZoolRes-38-4-171]). Global or conditional manipulation of *Mecp2* gene in Rett syndrome model mice is also sufficient to elicit SRS, including spontaneous epileptiform discharges ([@b11-ZoolRes-38-4-171]; [@b19-ZoolRes-38-4-171]; [@b76-ZoolRes-38-4-171]; [@b92-ZoolRes-38-4-171]). Mutations in the gene encoding SHANK3 and large duplications of the region spanning SHANK3 both cause ASD. Overexpression of SHANK3 in mice leads to SRS and maniac-like behavior ([@b29-ZoolRes-38-4-171]). The *Cntnap2* gene which encodes a transmembrane protein that is essential in interactions between neurons and glia is strongly associated with ASD. Deletion of *Cntnap2* leads to autistic-like behavior as well as SRS ([@b69-ZoolRes-38-4-171]).

Along these lines, disruption of non-ion channel genes involved in many other disorders with epileptic manifestation also results in SRS in mice. Disruption of fibroblast growth factors 13 (FGF13) on the X chromosome is associated with GEFS+. Female mice in which one *Fgf13* allele was deleted exhibited SRS ([@b71-ZoolRes-38-4-171]). Leucin-rich, glioma inactivated 1 (LGI1) is a secreted protein linked to human autosomal dominant epilepsy with auditory features (ADEAF). *Lgi1* deletion in mice results in early onset SRS and seizure-related death. Selective deletion of *Lgi1* in excitatory neurons, but not parvalbumin interneurons, contributes to the epileptic phenotype associated with LGI1 ([@b3-ZoolRes-38-4-171]; [@b10-ZoolRes-38-4-171]). The gene *Epm2a* has been indicated in an autosomal recessive disorder known as Lafora Disease. Deletion of *Epm2a* can cause spontaneous myoclonic seizures with approximately 80% penetrance at the age of 9 months ([@b25-ZoolRes-38-4-171]). Disruption of expression of doublecortin ([@b65-ZoolRes-38-4-171]), synapsin ([@b45-ZoolRes-38-4-171]), CELF4 ([@b88-ZoolRes-38-4-171]) or conditional expression of a constitutively active form of MAP/ERK kinases ([@b62-ZoolRes-38-4-171]) in the murine brain all led to SRS.

Besides genetically modified mice, SRS are also found in rats and mice with *de novo* mutations reported periodically in laboratories worldwide, like GAERS rat, WAG/Rij rat, lde/lde rat and *tg*, *tg^la^*, *rkr, lh, du, stz, wgl* mice ([@b63-ZoolRes-38-4-171]). Among these strains, GAERS rat and WAG/Rij rat are well validated genetic models of human absence epilepsy. Spontaneous absence seizures featuring SWD first appear at P30--P40 in GAERS rat, whereas they are observed at around P60--P80 in WAG/Rij rat. SWD in both strains are fully manifested with age and last throughout their lifetime ([@b17-ZoolRes-38-4-171]; [@b20-ZoolRes-38-4-171]; [@b56-ZoolRes-38-4-171]). The progression of absence seizures with age in WAG/Rij and GAERS rats resembles genetically-determined epileptogenesis similar to post-brain insult epileptogenesis ([@b75-ZoolRes-38-4-171]).

SRS in acquired models of epilepsy
----------------------------------

It is estimated that up to 50% of all epilepsy cases are initiated by neurological insults also known as acquired epilepsy. To model acquired epilepsy in rodents, an episode of prolonged seizures, namely status epilepticus (SE), is commonly induced to trigger SRS ([Table 2](#T2-ZoolRes-38-4-171){ref-type="table"}).

###### 

SRS in acquired models of epilepsy

  Insult                                       Methods                                                                           Features                                                                                              
  -------------------------------------------- --------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------
  SE                                           Pilocarpine (in the presence or absence of lithium)                               Systemic or intracerebral injection                                                                   High mortality in general and wide spread brain damage^\*^
  Kainic acid (KA)                             Systemic or intracerebral injection                                               Hippocampal restricted damage. Short latent period (e.g., 3--5 days, KA amygdala infusion in mouse)   
  Bicuculine after a lesion induced by DSP-4   Microinjection into anterior piriform cortex of rat                               30% developed SRS with mossy fiber sprouting                                                          
  Tetanus toxin                                Unilateral intrahippocampal injection in P10 rat                                  Early-life brain insult triggered diverse epileptiform response in adult rats                         
  Febrile seizures                             Hyperthermia in P10 rat                                                           Mimic etiology of TLE. 35.2% rats developed SRS in adults                                             
  Sustained electrical stimulation             In BLA or AB of rat                                                               Overall 80% (BLA) and 67% (AB) rats developed SRS                                                     
  TBI                                          CCI or LFP                                                                        \<50% developed SRS following TBI with long latent period^\*^                                         
  Ischemia/hypoxia                             Unilateral carotid ligation with hypoxia in P7 rat or global hypoxia in P10 rat   100% rats developed SRS, which propagated along time                                                  
  Methylazoxymethanol                          In utero exposure                                                                 2 out of 11 rats developed SRS                                                                        
  Virus infection                              Intracerebral infection with Theiler's murine encephalomyelitis virus             75% mice developed seizures 3--10 days post infection^\*^                                             
  Kindling                                     Over electrical kindling                                                          Repeated daily electrical stimulus for weeks and months                                               Labor intensive, SRS have not been well characterized
  Flurothyl kindling                           Repeated flurothyl induced convulsive seizures for 8 days (once/day)              SRS were observed within the first week following flurothyl kindling then remitted^\*^                

Post-SE models
--------------

Kainic acid (KA, an ionotropic glutamate receptors agonist) and pilocarpine (a cholinergic muscarinic agonist) are two of the most commonly used chemicals to trigger SE ([@b2-ZoolRes-38-4-171]; [@b1-ZoolRes-38-4-171]; [@b81-ZoolRes-38-4-171], [@b82-ZoolRes-38-4-171]). Systemic or intracerebral administration of KA causes SE followed by the emergence of SRS with remarkable histopathological correlation of hippocampal sclerosis in both rats and mice ([@b51-ZoolRes-38-4-171]). Compared to KA, pilocarpine-induced SE (in the presence or absence of lithium) results in higher mortality and wider spread brain damage in general along with SRS. The latency to onset of SRS and frequency of SRS varies depending on dose and administration route of chemicals as well as strains of animal. Convulsive SE can also be induced by microinjection of bicuculine into the anterior piriform cortex after a lesion of the locus coeruleus, which results in SRS in rat ([@b26-ZoolRes-38-4-171]). In addition to chemically-induced convulsive SE, convulsive or non-convulsive SE can be induced by sustained electrical stimulation in the angular bundle or the basolateral amygdala of a rat, and can evoke SRS along with hippocampal sclerosis ([@b5-ZoolRes-38-4-171]; [@b28-ZoolRes-38-4-171]; [@b64-ZoolRes-38-4-171]). SE that occurred during early developmental stage can also cause SRS in adults. Unilateral injection of tetanus toxin into the hippocampus of P10 rats produces recurrent seizures for one week followed by epileptiform burst discharges (electrographic seizures on rare occasions) in adults ([@b36-ZoolRes-38-4-171]; [@b50-ZoolRes-38-4-171]). Both longitudinal and retrospective clinical studies reveal early life febrile SE causes temporal lobe epilepsy (TLE) in adults. Similarly, prolonged febrile seizures induced by hyperthermia in P10 rats render 35.2% of them epileptic in adulthood ([@b22-ZoolRes-38-4-171]).

Brain insults
-------------

SRS can also develop following direct brain insults such as traumatic brain injury (TBI), stroke and viral infection in both human and rodents in the absence of SE. TBI caused by controlled cortical impact (CCI) or lateral fluid-percussion injury (FPI) is able to elicit SRS in rats and mice ([@b4-ZoolRes-38-4-171]; [@b18-ZoolRes-38-4-171]; [@b35-ZoolRes-38-4-171]; [@b46-ZoolRes-38-4-171]). Rats that experienced global hypoxia at P10 or hypoxic-ischemic insult at P7 developed progressive SRS in adulthood ([@b41-ZoolRes-38-4-171]; [@b73-ZoolRes-38-4-171]; [@b87-ZoolRes-38-4-171]). Rats exposed to methylazoxymethanol in utero exhibited altered GluRs expression and developed sporadic SRS in adulthood ([@b30-ZoolRes-38-4-171]). Viral encephalitis of the CNS causes severe brain damage and epilepsy. Libbey et al. described the first mouse model of viral-induced epilepsy after intracerebral infection with Theiler\'s murine encephalomyelitis virus, where the seizures were transient and remitted after 10 days post infection ([@b53-ZoolRes-38-4-171]; [@b52-ZoolRes-38-4-171]).

Kindling models
---------------

Kindling is the process in which a train of repeated subconvulsive or subthreshold stimuli (electrical, audiogenic or chemical) renders a naïve animal more susceptible to subsequent stimuli. Kindling is a canonical model used for the study of epileptogenesis, yet it receives increasing criticism due to the lack of SRS. However, over-electrical kindling ultimately results in SRS ([@b48-ZoolRes-38-4-171]; [@b58-ZoolRes-38-4-171]). Recent research revealed eight day consecutive flurothyl-kindling is sufficient to elicit SRS immediately after kindling, which remits weeks later ([@b42-ZoolRes-38-4-171]).

CONCLUDING REMARKS
==================

Chronic rodent SRS recording is fundamental to preclinical study of epilepsy. A lack of standard methodology for SRS recording hampers the reproducibility of available models as well as the discovery of novel animal models of SRS. We recommend chronic 24/7 simultaneous video-EEG recording for rigorous study of SRS in rodents, and the recording period should vary from weeks to months depending on the model that is being used. Exclusive EEG recording often results in false positives because movement artifacts from grooming, drinking, and eating frequently generate epileptiform-like activity with rhythmic increases of frequency and amplitude ([Figure 1B](#F1-ZoolRes-38-4-171){ref-type="fig"}, right panel). Simultaneous analysis of behavior and EEG is necessary because exclusive video monitoring commonly fails to identify focal seizures or absence seizures since these lack overt behavioral manifestations.

While there are many ways to model SRS in rodents, the researcher first needs to decide what type of epilepsy they want to most closely recapitulate. Idiopathic or acquired epilepsy? TLE or absence seizures? Then the researcher needs to weigh the risks and benefits of each model that is chosen by studying the mortality and success rates and taking into consideration the developmental stage, length of latent period, frequency of SRS, electrographic and behavioral features of SRS, etc. Successful implication of rodent model of SRS will facilitate our knowledge of epilepsy and finally lead to discovery of potential biomarkers and therapies.
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